Evaluation of the effects of vitamin D brain mapping in children with ADHD
Phase 3
- Conditions
- Attention-deficit hyperactivity disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20200922048802N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
7-13 years
Resident of Yazd
Increase theta wave above 7 hz and decrease beta below 13 hz
Exclusion Criteria
IQ less than 80
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Brain map. Timepoint: Befor and after 8 weeks treatment. Method of measurement: Brain mapping.;Vitamin D. Timepoint: Befor and after 8 weeks treatment. Method of measurement: Using ELISA.
- Secondary Outcome Measures
Name Time Method Weight. Timepoint: Before and after 8 weeks treatment. Method of measurement: Scale.;ADHD symptoms severity. Timepoint: Before and after 8 weeks treatment. Method of measurement: Conners parent rating scale checklist.;C reactive protein. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.;Malondialdehyde. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.;Nitric Oxide. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.